A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Clinical trial NCT05024032 · COMPLETED

Trial details

NCT number: NCT05024032
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Metabolism and Nutrition Disorder

Start date: 2021-09-01
Primary completion: 2022-12-27
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.